Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR52 | Q9Y2T5 | 13/20 | 0.47 |
| ▸ | EGFR | P00533 | 1/20 | 0.42 |
| ▸ | MAOB | P27338 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1814080 | 0.83 | GPR52 (0.48) | GPR52MAOB | |
| SCHEMBL23188649 | 0.82 | CYP1A2 (0.43) | GPR52 | |
| SCHEMBL755405 | 0.80 | TAAR1 (0.42) | MAOB | |
| SCHEMBL755404 | 0.80 | TAAR1 (0.42) | MAOB | |
| SCHEMBL9457643 | 0.80 | GPR52 (0.33) | GPR52 | |
| SCHEMBL9457648 | 0.80 | GPR52 (0.33) | GPR52 | |
| SCHEMBL7762166 | 0.79 | GPR52 (0.57) | GPR52MAOB | |
| SCHEMBL9715286 | 0.79 | GPR52 (0.57) | GPR52MAOB | |
| SCHEMBL7762164 | 0.79 | GPR52 (0.57) | GPR52MAOB | |
| SCHEMBL1157684 | 0.78 | GPR52 (0.42) | GPR52 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3189021-B1 | METATHESIS POLYMERIZATION METHODS | UNIV WASHINGTON (US) | 2025-05-14 | — | — | EP | disclosed |
| WO-2024204738-A1 | METHOD FOR PRODUCING 1,1-DIMETHYL-1,2-DIHYDRONAPHTHALENE | 持田製薬株式会社 | 2024-10-03 | — | — | WO | disclosed |
| US-11932714-B2 | Copolymer, film composition and composite material employing the same | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2024-03-19 | — | — | US | disclosed |
| US-20230063240-A1 | COPOLYMER, FILM COMPOSITION AND COMPOSITE MATERIAL EMPLOYING THE SAME | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2023-03-02 | — | — | US | disclosed |
| CN-115677932-A | Copolymer, film composition comprising the same, and composite material | 财团法人工业技术研究院 | 2023-02-03 | — | — | CN | disclosed |
| CN-108250720-B | Oligomer, composition containing same and composite material | 财团法人工业技术研究院 | 2021-03-23 | — | — | CN | disclosed |
| US-10907010-B2 | Metathesis polymerization methods | UNIVERSITY OF WASHINGTON (US) | 2021-02-02 | — | — | US | disclosed |
| US-20190211143-A1 | METATHESIS POLYMERIZATION METHODS | UNIVERSITY OF WASHINGTON (US) | 2019-07-11 | — | — | US | disclosed |
| US-10273327-B2 | Metathesis polymerization methods | UNIVERSITY OF WASHINGTON (US) | 2019-04-30 | — | — | US | disclosed |
| US-20170240695-A1 | METATHESIS POLYMERIZATION METHODS | UNIVERSITY OF WASHINGTON (US) | 2017-08-24 | — | — | US | disclosed |
| US-20170240695-A1 | METATHESIS POLYMERIZATION METHODS | UNIVERSITY OF WASHINGTON (US) | 2017-08-24 | — | — | US | disclosed |
| WO-2016036976-A1 | METATHESIS POLYMERIZATION METHODS | UNIVERSITY OF WASHINGTON (US) | 2016-03-10 | — | — | WO | disclosed |
| EP-1658298-B1 | PHOSPHORUS-CONTAINING IMIDAZOLINES AND METAL COMPLEXES THEREOF | SOLVIAS AG (CH) | 2008-03-26 | — | — | EP | disclosed |
| US-20070010493-A1 | Phospinite-imidazolines and metal complexes thereof | SOLVIAS AG (CH) | 2007-01-11 | — | — | US | disclosed |
| EP-1658298-A2 | NOVEL ORGANIC COMPOUNDS AND METAL COMPLEXES | Solvias AG (CH) | 2006-05-24 | — | — | EP | disclosed |
| WO-2005021562-A2 | PHOSPINITE-IMIDAZOLINES AND METAL COMPLEXES THEREOF | SOLVIAS AG (CH) | 2005-03-10 | — | — | WO | disclosed |
| EP-1478403-A1 | RESPONSIVE MICROGEL AND METHODS RELATED THERETO | SUPRATEK PHARMA, INC. (CA) | 2004-11-24 | — | — | EP | disclosed |
| WO-2003063909-A1 | RESPONSIVE MICROGEL AND METHODS RELATED THERETO | SUPRATEK PHARMA INC. (US) | 2003-08-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070010493-A1 | Phospinite-imidazolines and metal complexes thereof | H1-0, H1-2, H1-3 | GPR52 48/4885EGFR 1559/4885MAOB 2781/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.